Oct 13, 2026 03:04AM
Sep 23, 2026 04:01PM
Sep 23, 2026 04:01PM
Sep 16, 2026 04:01PM
Sep 16, 2026 04:01PM
Aug 27, 2026 07:09AM
Aug 21, 2026 08:00AM Gossamer Bio raises up to $250M in private placement for PAH drug
Aug 21, 2026 08:00AM
Aug 13, 2026 04:01PM
Jul 28, 2026 02:36AM
Jul 27, 2026 07:02AM
Jul 27, 2026 07:00AM
Jun 26, 2026 06:41AM
May 18, 2026 07:06AM Gossamer Bio launches debt exchange offer to eliminate $120 million
May 18, 2026 07:05AM
May 18, 2026 07:00AM
Mar 23, 2026 03:12AM
Mar 17, 2026 04:01PM
Feb 24, 2026 04:34AM
Feb 24, 2026 12:43AM
Feb 23, 2026 08:00AM Gossamer Bio's seralutinib misses primary endpoint in PAH trial
Feb 23, 2026 08:00AM
Nov 13, 2025 07:29AM
Sep 25, 2025 07:41AM
Sep 25, 2025 07:41AM
Sep 25, 2025 07:31AM
Sep 25, 2025 07:31AM
May 15, 2025 04:01PM Gossamer Bio Announces First Quarter 2025 Financial Results and Provides Business Update, Including Closure of New Patient Screening in Phase 3 PROSERA Study
Oct 31, 2024 07:00AM
Mar 12, 2024 07:32AM
Mar 12, 2024 07:31AM
May 18, 2023 07:05AM
May 9, 2023 04:01PM
Apr 3, 2023 04:04PM
Mar 17, 2023 07:31AM Gossamer Bio Announces Fourth Quarter and Full-Year 2022 Financial Results and Provides Business Update
Apr 25, 2022 08:54AM
Mar 3, 2022 04:01PM
Mar 5, 2021 06:23PM
Feb 25, 2021 07:31AM
Dec 7, 2020 07:03AM
Oct 13, 2020 07:05AM
Oct 13, 2020 07:04AM Gossamer Bio Announces Topline Results for Phase 2 Trials of Oral GB001 in Asthma and Chronic Rhinosinusitis
Sep 1, 2020 04:30PM
May 27, 2020 04:36PM
May 27, 2020 04:30PM
May 27, 2020 04:30PM
May 12, 2020 04:01PM
Nov 12, 2019 04:05PM
Nov 12, 2019 07:13AM Gossamer Bio (GOSS) Announces Clinical Trial Collaboration Agreement With Merck to Evaluate GB1275 in Combination With KEYTRUDA
Nov 12, 2019 07:00AM

334,273 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All